Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+209K
-
Total reported value, excl. options
-
$188M
-
Value change
-
-$4.72M
-
Put/Call ratio
-
0.4
-
Number of buys
-
38
-
Number of sells
-
-70
-
Price
-
$7.05
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2016
141 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q1 2016.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 119M outstanding shares and own 22.31% of the company stock.
Largest 10 shareholders include BVF INC/IL (4.34M shares), LANSDOWNE PARTNERS (UK) LLP (2.32M shares), FMR LLC (2.12M shares), EcoR1 Capital, LLC (2.05M shares), WELLINGTON MANAGEMENT GROUP LLP (1.93M shares), VANGUARD GROUP INC (1.47M shares), BlackRock Institutional Trust Company, N.A. (1.32M shares), ACADIAN ASSET MANAGEMENT LLC (1.22M shares), BlackRock Fund Advisors (888K shares), and CITIGROUP INC (745K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.